Clipboard Health vs Moderna

Side-by-side comparison of AI visibility scores, market position, and capabilities

Moderna leads in AI visibility (90 vs 79)
Clipboard Health logo

Clipboard Health

LeaderHealthcare

General

Healthcare per-diem staffing marketplace with 90%+ shift-fill rate and $100M revenue; profitable since 2022 backed by Sequoia competing with Shiftkey and CareRev for nurse per-diem placement.

AI VisibilityBeta
Overall Score
B79
Category Rank
#28 of 596
AI Consensus
74%
Trend
stable
Per Platform
ChatGPT
76
Perplexity
84
Gemini
79

About

Clipboard Health is a healthcare staffing marketplace that connects per-diem nurses, CNAs, and allied health professionals with healthcare facilities (nursing homes, hospitals, urgent care centers) for shift work — achieving a 90%+ shift-fill reliability rate versus the 60% industry average for traditional staffing agencies, and maintaining profitability since 2022. A Y Combinator graduate, Clipboard Health reached $100 million in annual revenue within three years of founding, raised $94.1 million total led by Sequoia Capital, and serves tens of thousands of healthcare professionals across 1,000+ facilities.

Full profile
Moderna logo

Moderna

LeaderHealthcare Tech

Enterprise

mRNA pioneer with $3.2B FY2024 revenue (down from $18.4B 2022 COVID peak); mRESVIA RSV vaccine approved 2024; personalized cancer vaccine with Merck shows 44% recurrence reduction in melanoma.

AI VisibilityBeta
Overall Score
A90
Category Rank
#2 of 596
AI Consensus
83%
Trend
stable
Per Platform
ChatGPT
92
Perplexity
93
Gemini
89

About

Moderna is a clinical-stage biotechnology company that pioneered the development of messenger RNA (mRNA) therapeutics and vaccines, founded in 2010 by Noubar Afeyan, Robert Langer, Kenneth Chien, Stéphane Bancel, and others in Cambridge, Massachusetts, where it is headquartered and trades on Nasdaq (MRNA). The company achieved extraordinary commercial success with Spikevax, its COVID-19 mRNA vaccine developed in partnership with the U.S. government in 2020—generating $18.4 billion in COVID vaccine revenues in 2022 at peak—before experiencing a severe revenue decline as global COVID booster demand normalized. For FY2024, Moderna generated approximately $3.2 billion in revenues, with Spikevax and the reformulated XBB.1.5-targeting COVID vaccine contributing the majority, while the company's significant R&D investment pipeline consumed most operating cash flows.

Full profile

AI Visibility Head-to-Head

79
Overall Score
90
#28
Category Rank
#2
74
AI Consensus
83
stable
Trend
stable
76
ChatGPT
92
84
Perplexity
93
79
Gemini
89
76
Claude
96
85
Grok
95

Key Details

Category
General
Enterprise
Tier
Leader
Leader
Entity Type
brand
company

Track AI Visibility in Real Time

Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.